| Fibroma |
0 |
1 |
| Pregnancy |
0 |
0.9 |
| Fertility |
0 |
0.8 |
| Uterus |
0 |
0.75 |
| Dysfunctional Uterine Bleeding |
0 |
0.16 |
| Infertility Female |
0 |
0.3 |
| Robotic Surgery |
0 |
0.15 |
| Surgery |
0 |
0.95 |
| Ultrasonography |
0 |
0.15 |
| Thromboembolism |
0 |
0.14 |
| In Vitro Fertilization |
0 |
0.13 |
| Obesity |
0 |
0.13 |
| Tissue |
0 |
0.1 |
| Gonadotropin-Releasing Hormone (GnRH) Agonists |
0 |
0.09 |
| Contraception |
0 |
0.08 |
| Pain Management |
0 |
0.08 |
| Gonadotropin-Releasing Hormone (GnRH) Antagonist |
0 |
0.07 |
| Anemia |
0 |
0.06 |
| Blood |
0 |
0.06 |
| Hemorrhage |
0 |
0.06 |
| Pain |
0 |
0.06 |
| Bone Density |
0 |
0.05 |
| Postpartum Hemorrhage |
0 |
0.05 |
| Ablation |
0 |
0.04 |
| Amenorrhea |
0 |
0.04 |
| Bone |
0 |
0.04 |
| Dorsum |
0 |
0.04 |
| Florida |
0 |
0.04 |
| Hormonal Contraception |
0 |
0.04 |
| Infertility |
0 |
0.04 |
| Laparoscopy |
0 |
0.04 |
| Spontaneous Abortion |
0 |
0.04 |
| Tumor |
0 |
0.04 |
| Wound Management |
0 |
0.04 |
| Anatomy |
0 |
0.02 |
| Artery |
0 |
0.02 |
| Burnout |
0 |
0.02 |
| Cesarean Delivery |
0 |
0.02 |
| Coagulation |
0 |
0.02 |
| Embolization |
0 |
0.02 |
| Endometriosis |
0 |
0.02 |
| Fever |
0 |
0.02 |
| Food and Drug Administration (FDA) |
0 |
0.02 |
| Health Care Quality, Access, and Evaluation |
0 |
0.02 |
| Hypertension |
0 |
0.02 |
| Hysterectomy |
0 |
0.02 |
| Hysteroscopy |
0 |
0.02 |
| Injury |
0 |
0.02 |
| Intrauterine Device |
0 |
0.02 |
| laparotomy |
0 |
0.02 |
| Leiomyoma |
0 |
0.02 |
| Leukocytosis |
0 |
0.02 |
| Magnetic Resonance Imaging |
0 |
0.02 |
| Menometrorrhagia |
0 |
0.02 |
| Menopause |
0 |
0.02 |
| Meta-Analysis |
0 |
0.02 |
| Minerals |
0 |
0.02 |
| Muscle |
0 |
0.02 |
| Nausea |
0 |
0.02 |
| Pituitary Gland |
0 |
0.02 |
| Postpartum |
0 |
0.02 |
| Preterm Labor |
0 |
0.02 |
| Quality of Life |
0 |
0.02 |
| Receptors |
0 |
0.02 |
| Social Determinants of Health |
0 |
0.02 |